0001564590-16-019740 Sample Contracts

Controlled Equity OfferingSM Sales Agreement
Cidara Therapeutics, Inc. • May 20th, 2016 • Biological products, (no disgnostic substances) • New York

Cidara Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

AutoNDA by SimpleDocs
CIDARA THERAPEUTICS, INC. FORM OF COMMON STOCK WARRANT AGREEMENT
Common Stock Warrant Agreement • May 20th, 2016 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

This Common Stock Warrant Agreement (this “Agreement”), dated as of [●], between Cidara Therapeutics, Inc., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Cidara Therapeutics, Inc. and _____________, As Warrant Agent Form Of Preferred Stock Warrant Agreement Dated As Of __________
Preferred Stock Warrant Agreement • May 20th, 2016 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

This Preferred Stock Warrant Agreement (this “Agreement”), dated as of [●], between Cidara Therapeutics, Inc., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Cidara Therapeutics, Inc. and _____________, As Warrant Agent Form Of Debt Securities Warrant Agreement Dated As Of __________
Securities Warrant Agreement • May 20th, 2016 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

This Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between Cidara Therapeutics, Inc., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

CIDARA THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 20__ Debt Securities
Indenture • May 20th, 2016 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Time is Money Join Law Insider Premium to draft better contracts faster.